{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:49:05Z","timestamp":1780566545120,"version":"3.54.1"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Hereditary protein C deficiency (HPCD) is a rare autosomal dominant thrombophilia caused by PROC gene mutations, predisposing patients to venous thrombosis. Patent foramen ovale (PFO) with right-to-left shunt (RLS) may facilitate paradoxical embolism, increasing the risk of stroke and pulmonary embolism. However, the coexistence of HPCD and PFO leading to multisystem embolism has not been previously reported. We report a 29-year-old woman presenting with sudden-onset altered consciousness. The patient had no traditional cerebrovascular risk factors other than oral contraceptive use. Imaging revealed basilar artery occlusion, left pulmonary embolism, and bilateral iliac vein thrombosis. Laboratory testing demonstrated reduced protein C activity, and genetic analysis identified a heterozygous pathogenic PROC variant (c.541T&amp;gt;G, p.Phe181Val). Transcranial Doppler bubble study, transesophageal echocardiography (TEE), and agitated saline contrast echocardiography (ASCE) confirmed a PFO with grade 3 RLS. The patient was diagnosed with HPCD combined with PFO. She underwent emergent mechanical thrombectomy, inferior vena cava (IVC) filter placement, subsequent PFO closure, and lifelong rivaroxaban therapy. At 1-year follow-up, she exhibited excellent clinical recovery with complete resolution of symptoms and no evidence of recurrent thromboembolic events. This first-reported case highlights the potential synergistic thrombotic risk of coexisting HPCD and PFO. For patients with unexplained multisystem embolism, thorough evaluation of both conditions is essential, and individualized comprehensive treatment strategies are crucial for a good prognosis.<\/jats:p>","DOI":"10.3389\/fcvm.2025.1650286","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T05:36:50Z","timestamp":1756877810000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Multisystem embolism in hereditary protein C deficiency with patent foramen ovale: a case report"],"prefix":"10.3389","volume":"12","author":[{"given":"Lihua","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1007\/s00277-024-05674-3","article-title":"Analysis of four hereditary protein C deficiencies associated with vascular thromboembolism","volume":"103","author":"Chen","year":"2024","journal-title":"Ann Hematol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.5858\/arpa.2017-0403-RS","article-title":"Protein C deficiency","volume":"143","author":"Dinarvand","year":"2019","journal-title":"Arch Pathol Lab Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e631","DOI":"10.1002\/mco2.631","article-title":"Congenital heart disease: types, pathophysiology, diagnosis, and treatment options","volume":"5","author":"Meng","year":"2024","journal-title":"MedComm"},{"key":"B4","doi-asserted-by":"publisher","first-page":"15086","DOI":"10.1038\/nrdp.2015.86","article-title":"Patent foramen ovale","volume":"2","author":"Homma","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12959-023-00548-6","article-title":"Evaluation of prothrombotic risk of two PROC hotspot mutations (Arg189Trp and Lys193del) in Chinese population: a retrospective study","volume":"21","author":"Li","year":"2023","journal-title":"Thromb J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1055\/s-0037-1613820","article-title":"Protein C deficiency and venous thrombosis\u2013the search for the second genetic defect","volume":"83","author":"Bertina","year":"2000","journal-title":"Thromb Haemostasis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.5853\/jos.2024.02670","article-title":"Patent foramen ovale and other cardiopathies as causes of embolic stroke with unknown source","volume":"26","author":"Kim","year":"2024","journal-title":"J Stroke"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e231934","DOI":"10.1148\/radiol.231934","article-title":"MRI in the evaluation of cryptogenic stroke and embolic stroke of undetermined source","volume":"311","author":"Xiao","year":"2024","journal-title":"Radiology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1016\/j.jtha.2024.05.011","article-title":"Genome-wide investigation of exogenous female hormones, genetic variation, and venous thromboembolism risk","volume":"22","author":"Hasser","year":"2024","journal-title":"J Thromb Haemostasis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1056\/NEJMoa2207576","article-title":"Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion","volume":"387","author":"Jovin","year":"2022","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1016\/j.jacc.2018.02.046","article-title":"Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial","volume":"71","author":"Lee","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1056\/NEJMc2033779","article-title":"Five-year outcomes of PFO closure or antiplatelet therapy for cryptogenic stroke","volume":"384","author":"Kasner","year":"2021","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1161\/STROKEAHA.120.029350","article-title":"Risk of paradoxical embolism (RoPE)\u2014estimated attributable fraction correlates with the benefit of patent foramen ovale closure: an analysis of 3 trials","volume":"51","author":"Kent","year":"2020","journal-title":"Stroke"},{"key":"B14","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1055\/s-0044-1786356","article-title":"Limb ischemic necrosis secondary to microvascular thrombosis: a brief historical review","volume":"50","author":"Warkentin","year":"2024","journal-title":"Semin Thromb Hemost"},{"key":"B15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1182\/bloodadvances.2017014593","article-title":"Rivaroxaban dose adjustment using thrombin generation in severe congenital protein C deficiency and warfarin-induced skin necrosis","volume":"2","author":"Menon","year":"2018","journal-title":"Blood Adv"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1016\/j.jtha.2024.08.006","article-title":"The use of direct oral anticoagulants in the secondary prevention of venous thromboembolism in patients with severe thrombophilia: communication from the ISTH SSC subcommittee on physiological anticoagulants and thrombophilia","volume":"22","author":"Kovac","year":"2024","journal-title":"J Thromb Haemostasis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e018917","DOI":"10.1161\/JAHA.120.018917","article-title":"Direct oral anticoagulants in patients with inherited thrombophilia and venous thromboembolism: a prospective cohort study","volume":"9","author":"Campello","year":"2020","journal-title":"J Am Heart Assoc"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1650286\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T05:36:51Z","timestamp":1756877811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1650286\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":17,"alternative-id":["10.3389\/fcvm.2025.1650286"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1650286","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,3]]},"article-number":"1650286"}}